ACTA1 and metabolic dysfunction-associated steatohepatitis: Co‐localization of TWEAK with α‐SMA and vimentin confirmed the expression of TWEAK by hepatic myofibroblasts; it also showed co‐localization of TWEAK with HSCs/myofibroblasts in the sinusoids in NASH livers (Figure 3C).